Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, and surgical
resection is a requirement for a potential cure. However, the majority of patients are …

Purpose Although surgery is the standard of care for resectable pancreatic cancer (PC),
standard-dose chemoradiation therapy and chemotherapy alone are suitable for patients …

Background Adaptive magnetic resonance imaging‐guided radiation therapy (MRgRT) can
escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of …

Purpose To provide evidence-based recommendations to oncologists and others for
treatment of patients with locally advanced, unresectable pancreatic cancer. Methods …

PURPOSE: Stereotactic body radiation therapy (SBRT) provides high rates of local control
(LC) and margin-negative (R0) resections for locally advanced pancreatic cancer (LAPC) …

Purpose. Limited data are available to guide neoadjuvant treatment of borderline resectable
(BRPC) and locally advanced (LAPC) pancreatic cancer. Material and methods. We updated …

Purpose Patients with inoperable pancreatic adenocarcinoma have limited options, with
traditional chemoradiation providing modest clinical benefit and an otherwise poor …

Background The goal of this study was to characterize the efficacy and safety of stereotactic
body radiation therapy (SBRT) versus conventionally fractionated radiation therapy with …

Background Locally advanced pancreatic cancer (LAPC) is associated with a very poor
prognosis. Current palliative (radio) chemotherapy provides only a marginal survival benefit …

Background and purpose We conducted a prospective, in silico imaging clinical trial to
evaluate the feasibility and potential dosimetric benefits of computed tomography-guided …